Biogen (BIIB) Change in Acquisitions & Divestments (2009 - 2026)

Biogen (BIIB) recorded quarterly Change in Acquisitions & Divestments of $500000.0 in Q1 2026, up 101.49% quarter-over-quarter from -$33.6 million in Q4 2025.

Biogen (BIIB) Change in Acquisitions & Divestments (2009 - 2026) Analysis & Trends

Biogen's Change in Acquisitions & Divestments history runs 18 years deep, the most recent figure standing at $500000.0 for Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $500000.0; the TTM figure through Mar 2026 stood at $23.5 million (up 142.27% YoY), while the FY2025 annual figure was $23.0 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments was $500000.0 for Q1 2026 at Biogen, up from -$33.6 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $5.7 billion in Q3 2023 to a low of -$96.7 million in Q4 2024.
  • Historically, Change in Acquisitions & Divestments has averaged $791.1 million across 5 years, with a median of $231.6 million in 2023.
  • The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments jumped 246.8% in 2023, then slumped 99.85% in 2024.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $566.3 million in 2022, then jumped by 906.29% to $5.7 billion in 2023, then sank by 101.7% to -$96.7 million in 2024, then jumped by 65.25% to -$33.6 million in 2025, then surged by 101.49% to $500000.0 in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $500000.0 (Q1 2026), -$33.6 million (Q4 2025), and $56.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Biogen 28.75 Bn 24.47 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 500,000.00
Mar 31, 2026 500,000.00
Dec 31, 2025 -33.60 Mn
Dec 31, 2025 -33.60 Mn
Sep 30, 2025 56.60 Mn
Sep 30, 2025 56.60 Mn
Dec 31, 2024 -96.70 Mn
Dec 31, 2024 -96.70 Mn
Sep 30, 2024 39.20 Mn
Sep 30, 2024 39.20 Mn
Jun 30, 2024 1.90 Mn
Jun 30, 2024 1.90 Mn
Mar 31, 2024 55.60 Mn
Mar 31, 2024 55.60 Mn
Sep 30, 2023 5.70 Bn
Sep 30, 2023 5.70 Bn
Jun 30, 2023 1.28 Bn
Jun 30, 2023 1.28 Bn
Mar 31, 2023 406.70 Mn
Mar 31, 2023 406.70 Mn